A research showed that miR-378a-3p was related with favorable prognosis in ovarian cancer, which could suppress cell proliferation, promote cell apoptosis, and enhance the sensitivity to cisplatin by sponging MAPK1 and GRB2 (36). Here, MAPK1 is linked to ovarian carcinoma.